Sexually transmitted disease - Bone Marrow and Peripheral Blood Stem Cell
Also known as: STD
Scenarios
Affected individual
- Includes
- Excludes
- Obligatory
See: is there is a specific entry for the disease?
Must not donate.
- Discretionary
If fully treated, at least three months from completion of treatment, accept. Additionally, for gonorrhoea, evidence of a test of cure after treatment is required. This may be a verbal confirmation, provided by the donor.
Sexual partner of affected individual
- Includes
- Excludes
- Obligatory
See: is there is a specific entry for the disease with which there has been contact?
Must not donate if:
- Donor required treatment and it is less than three months since completing that treatment.
- Donor did not require treatment and it is less than three months from the last sexual contact with the infected partner.
- Discretionary
- Donor did not require treatment and it is more than three months since the infected partner has completed treatment, accept.
- Donor required treatment: if fully treated, and if it is at least three months from completion of treatment, accept. Additionally, for gonorrhoea, evidence of a test of cure after treatment is required. This may be a verbal confirmation, provided by the donor.
- If the donor’s sexual partner has been diagnosed with chlamydia (except lymphogranuloma venereum, see (b) above), genital warts or genital herpes and the donor is asymptomatic and not undergoing treatment or investigation, accept.
- Additional information
Guidelines (NICE, BASHH) recommend that current sexual partners of lymphogranuloma venereum (LGV) probable or confirmed individuals should receive testing and empiric treatment with a chlamydial regimen. They can be accepted 3 months after completion of treatment.
Supporting information
- Reason for change:
- 'See if Relevant' links have been updated.
- Version details:
BM-DSG Edition 203 Release 61 (13 October 2025)